Immunology, hepatology and intensive care, pulmonology, hematology, neurology.

Verkkoa review of the current landscape for rare diseases, which affect 300 million people worldwide and have high genetic and diagnostic complexity.

Targeted complement 5 inhibitor zylbrysq (zilucoplan).

Recommended for you

Verkkogrifols is accelerating adoption of xembifyยฎ as part of its broader immunoglobulin business strategy focused on treating immunodeficiency disorders,.

Verkkogrifolsโ€™ fanhdi showed it could be effective, safe and well tolerated in the management of bleeding episodes and for the prevention of bleeding during surgeries in patients with von willebrand disease (vwd)

Verkkogrifols is focused on treating conditions across a broad range of therapeutic areas:

Verkkothis article analyses the main therapeutic modalities available to researchers interested in translating advances in the scientific understanding of rare.

You may also like